Monday, March 16, 2026

Beyond China: Kim Jong Un’s True Motives for Attending Victory Day Celebration

Kim Jong Un's attendance at China's Victory Day aims to strengthen ties with China and Russia while creating internal discord in South Korea.

NewJeans’ ‘Ditto’ Makes Waves as One of the Best Songs of the 2020s!

Paste magazine recognized the K-pop girl group NewJeans' single "Ditto" as one of the Best Songs of the 2020s. 

Lose-Lose ASIA: U.S. Nuclear Secrecy Is Broken—Either We Fuel Korea’s Subs Or We Leave Them Defenseless Against Kim

Wi Sung-lac discusses President Lee's request for nuclear submarines amid North Korea's threats and the U.S.-Korea summit outcomes.

Jung Eun Kim

GCCell Secures Groundbreaking Patent for Next-Gen Cell Therapy: What It Means for the Future of Immunotherapy

GC Cell has completed the registration of core technology patents for next-gen cell and gene therapies in South Korea and Japan.

Unlocking Weight Loss: How Celltrion’s New CT-G32 and Oral Multi-Action Drug Will Change the Game

Celltrion aims to lead the obesity treatment market with innovative drugs, enhancing efficacy and patient convenience through dual approaches.

A New Hair-Growth Pathway?: JW0061 Targets GFRA1 After 7.2x Organoid Results and a 39% Animal Boost

JW Pharmaceutical's hair loss treatment JW0061 gains FDA approval for clinical trials, promising innovative growth stimulation for men and women.

CT-P55: How Celltrion’s New Biosimilar Approval Will Transform Clinical Trials in Europe

Celltrion receives EMA approval to reduce patient enrollment for CT-P55 trial, aiming to cut costs and duration of clinical development.

Wontek’s V-Laser Approved for Versatile Treatments in Vietnam: A Game-Changer for Aesthetic Clinics

Wontech secures medical device approval for its V-Laser in Vietnam, enhancing its product lineup and market presence in medical aesthetics.

Medipost’s Cartistem: Achieving 3000 Knee Cartilage Restoration Surgeries – A Game Changer for Osteoarthritis Treatment

Medipost's Cartistem therapy reaches 3,000 procedures for cartilage restoration, proving its safety and efficacy for knee osteoarthritis.

Why Centrum Multivitamins Are Backed by 32 Clinical Studies: A Deep Dive into Their Proven Benefits

Centrum multivitamins stand out for their extensive research backing, showing benefits in cancer risk reduction and cognitive function.

Celltrion’s Remsima Surpasses 1 Trillion KRW in Sales for 2nd Consecutive Year: What’s Driving Its Success?

Celltrion's Remsima treatment surpasses 1 trillion KRW in sales, driven by European market growth and new liquid formulation.

Samsung Biologics Partners with CEPI: A Game-Changer for Global Vaccine Production

Samsung Biologics partners with CEPI to enhance vaccine production for pandemics, aiming for rapid global supply and health security.

HM15275 Clinical Trials: What You Need to Know About This Groundbreaking Obesity Treatment

Hanmi Pharmaceutical's HM15275 enters Phase 2 trial, aiming to revolutionize obesity treatment and diabetes management by 2030.

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

Pneumonia Death Rates in South Korea: Why Vaccination is Crucial for High-Risk Groups

Pneumonia is South Korea's third leading cause of death; prevention is crucial, especially for high-risk groups after influenza.

Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Samsung Bioepis has secured a licensing deal for its ophthalmic treatment SB15, expanding access in international markets outside the US and Canada.

How Celltrion is Tackling U.S. Tariff Risks with New Production Facility in 2026

Celltrion addresses tariff risks by acquiring a U.S. facility, ensuring product supply and implementing strategies to mitigate uncertainties.

Top News

- Our Sponsors Ad -

Follow us